• The Next Trick For CRISPR Is Gene-Editing Pain Away

    MIT Technology Review | A family of street performers could walk on coals. Scientists have paired the discovery with the gene-editing tool CRISPR, in what they say is a step toward a gene therapy that could block severe pain caused by diabetes, cancer, or car accidents without the addictive effects of opioids.

    Aug 23, 2019

  • Color Receives Genetic Counseling Grant for All of Us

    Bio-IT World  | The All of Us research program has awarded $4.6 million in initial funding to Color, a health technology company in Burlingame, California, to establish the program’s nationwide genetic counseling resource. Through this funding, Color’s network of genetic counselors will help participants understand what the genomic testing results mean for their health and their families.

    Aug 21, 2019

  • U.K. Firm Creates Operating System To Handle Massive Genomic Patient Data Sets

    Forbes | We're making work digital on every desktop, we're empowering digital sensors in the Internet of Things (IoT) on every street corner, we're building smart digital AI-powered IT systems with machine learning and decision-making abilities to automate our lives… and we're digitizing ourselves as well.

    Aug 16, 2019

  • 20% Enrollment For All of Us Program, Challenges Remain

    Bio-IT World | The All of Us research program announced updates today in a special report published in the New England Journal of Medicine. As of July 2019, the All of Us program has enrolled more than 175,000 core participants (those who contributed personal information, biospecimens, and physical measurements and who agreed to share EHR data) and more than 230,000 total participants; an additional 40,000 participants have registered on the website, the authors report. “More than 80% of these participants are from groups that have been historically underrepresented in biomedical research,” the authors observe.

    Aug 15, 2019

  • Tackling the Affinity Gap at Amgen

    Bio-IT World At Amgen, Agnieszka Kielczewska had a problem. The AMGN12 antibody, derived from an in vivo immunization of the XenoMouse, demonstrated single digit pM affinity to the human orthologue of the target protein, but a 200-fold weaker binding to the monkey orthologue. In order to conduct toxicology studies in non-human primate species, Amgen needed that affinity difference to be closer to 10-fold.

    Aug 14, 2019

  • Nvidia just made it easier to build smarter chatbots and slicker fake news

    MIT Technology Review | Chipmaker Nvidia is betting that AI's language skills will advance rapidly-it's releasing a powerful tool for putting together chatty programs.

    Aug 13, 2019

  • Biobanking Is Changing The World

    Forbes | With the evolution of biobanks rapidly enabling the creation of massive collections of biological material and associated information, how are these collected terabytes of data transforming nations?

    Aug 13, 2019

  • National Genomic Data Initiatives: A Worldwide Update

    Bio-IT World | The global movement toward the application of genomics to medical practice is exciting because it is essentially "precision medicine come real," says Ewan Birney, chair of the Global Alliance for Genomics and Health (GA4GH). But which countries are involved? And what progress has been made so far? Bio-IT World’s overview offers an update on currently active national government-funded genomic-medicine initiatives, grouped by area of emphasis.

    Aug 12, 2019

  • Bacteria On Tumors Influences Immune Response, Survival Of Patients With Pancreatic Cancer

    Bio-IT World News Brief | A team led by researchers from The University of Texas MD Anderson Cancer Center reports that a key difference between the few pancreatic cancer patients who survive long-term and the many whose disease overcomes all treatments is the bacterial signatures on their tumors that either stimulate or suppress immune response.

    Aug 9, 2019

  • Patentable Subject Matter In Bioinformatics After USPTO’s January Guidance: Easier To Obtain, But Harder To Keep

    Bio-IT World Contributed Commentary | The United States Patent and Trademark Office released new guidance earlier this year that appears to have somewhat reversed the trend of increased patentable subject matter ineligibility for bioinformatics patent applications.

    Aug 5, 2019

  • CRISPR Patents, Oxford Nanopore, Komodo Dragons, And More: News From July 2019

    Bio-IT World | July featured exciting news, products, and partnerships from around the bio-IT community including CRISPR patents, Oxford Nanopore, the first high-resolution sequence of the Komodo dragon, and more.

    Jul 31, 2019

  • How PetaGene 'Nailed It' With Their PetaSuite Protect

    Bio-IT World | With the rapid growth of genomic data and the need for access by cross-functional teams, it is vital to ensure that this sensitive data is adequately protected and monitored. PetaGene's PetaSuite Protect ensures that protection.

    Jul 29, 2019

  • Novo Nordisk: Natural Language Processing On A Steady Diet Of Real-World Data

    Bio-IT World | Natural language processing is finding novel applications at Novo Nordisk, turning a trio of real-world data sources into a goldmine of knowledge about the medicines it makes, the healthcare providers who prescribe them, and patients who usually pay for a portion of the cost.

    Jul 29, 2019

  • First CRISPR Study Inside The Body To Start In US

    STAT | Patients are about to be enrolled in the first study to test a gene-editing technique known as CRISPR inside the body to try to cure an inherited form of blindness.

    Jul 25, 2019

  • Machine Reasoning Extends AI's Scope In Clinical Data Quality And Research

    Bio-IT World Contributed Commentary | Clinicians are faced with tedious data entry that can benefit by unobtrusive input verification and auto-completion. Coupling traditional data quality methods with AI makes it possible to efficiently solve issues like ensuring correct data, reporting to related systems, identifying medicine interactions, improving care processes—without changing clinical workflows.

    Jul 24, 2019

  • Genedata's 'No BS AI'

    Bio-IT World | Genedata recently won Bio-IT World's "No BS AI" Best of Show Award during the Bio-IT World Conference & Expo for its deep learning-based solution for phenotypic imaging and corresponding workflows, Imagence.

    Jul 22, 2019

  • 5 Ways To Keep Your Life Sciences Startup From Becoming Theranos

    Bio-IT World Contributed Commentary | Transparency is critical for all industries these days, but especially for the life sciences sector. When it comes to innovative services and products from emerging life sciences companies, transparency can be pivotal to preventing fraud and wasted investments.

    Jul 18, 2019

  • How The Parker Institute Addresses Tumor-Specific T Cells

    Bio-IT World | As a Senior Data Scientist at the Parker Institute for Cancer Immunotherapy, Daniel Wells sees how discoveries in immunotherapy are rapidly changing how researchers develop treatment strategies for patients by integrating multiple molecular and clinical data types.

    Jul 17, 2019

  • Building A Marriage Between Medicine And Tech

    Bio-IT World | John-William Sidhom says the ideal scenario would be to have a system where scientific research asks the relevant questions, tech provides answers to those questions, and the physician implements those solutions for the most clinical impact.

    Jul 12, 2019

  • St. Jude Announces Availability Of Clinical Genome Sequencing Data In Real Time Via Cloud

    Bio-IT World | St. Jude Children's Research Hospital has announced the real-time availability of clinical genome sequencing data on the St. Jude Cloud.

    Jul 11, 2019